Loveland, CO – According to filings with the U.S. Securities and Exchange Commission, Heska Corporation is raising $122,000,000.00 in new funding. Sources indicate as part of senior management Chief Financial Officer, Catherine Grassman played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Heska Corporation

Through innovation, invention, and strategic partnerships with worldwide leaders in diagnostics and treatments, Heska provides the benefits of latest generation technologies to pet healthcare providers. Heska’s range of complete blood diagnostic solutions include Chemistry, Hematology, Blood Gas & Electrolytes, Immunodiagnostics, Heartworm, and other blood testing. Treatments and testing include Immunotherapy and complete Allergy solutions. Heska’s digital imaging lineup boasts the latest High Definition Digital Radiography and Digital Ultrasound technologies, paired with Cloud Based data archival, management, and sharing services.

To learn more about Heska Corporation, visit http://www.heska.com/

Contact:
Catherine Grassman, Chief Financial Officer
970-493-7272

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved